- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0037959

About Jeevan Scientific Technology Limited
Data last updated:
Jeevan Scientific Technology Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 02 February 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN L72200TG1999PLC031016. Its GSTIN is 36AAACJ8112F1ZV (Telangana). It is a listed company as per MCA records. Its shares are listed on BSE: 538837.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.08 Cr. It was formerly known as Jeevan Softech Limited and Jeevan Softech Private Limited. It is led by directors including Krishna Kishore Kuchipudi (Managing Director) and Nageswar Rao Yarllagadda (Whole-Time Director).
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 1 & 2 Sai Krupa Enclave Manikonda Jagir Near Lanco Hills, Hyderabad, Telangana, India – 500008.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹61.54 Cr, a growth of 31.4% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Cr (net margin 1.9%) and EBITDA of ₹9.8 Cr (EBITDA margin 15.9%).
The company has about 306 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 2 brands: Jeevan Climate and Jeevan Scientific Technology. As per MCA filings, the company has open charges of ₹27.86 Cr and satisfied charges of ₹19.2 Cr on record. The company has 10 deals on record (10 market trades); the latest was in October 2025. Its 3 peer companies in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities) are compared by revenue, 2 larger and 1 smaller; the largest is Alvogen Pharma (India) Private Limited with revenue of ₹51.32 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2020, listing 262 overdue payments to 19 micro and small suppliers.
Jeevan Scientific Technology Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0037959). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jeevanscientific.com.
Company details
Name history
Jeevan Scientific Technology has undergone 2 name changes throughout its history. The company was previously known as Jeevan Softech Limited, and Jeevan Softech Private Limited. The current legal name is Jeevan Scientific Technology Limited.
| Company Name | Status |
|---|---|
| Jeevan Scientific Technology Limited | Current |
| Jeevan Softech Limited | Previous |
| Jeevan Softech Private Limited | Previous |
CIN history
Jeevan Scientific Technology has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L72200TG1999PLC031016, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L72200TG1999PLC031016 | Current |
| L72200AP1999PLC031016 | Previous |
| U72200AP1999PLC031016 | Previous |
Recognitions & Rankings of Jeevan Scientific Technology
Contact details
Jeevan Scientific Technology Limited's registered office is in Hyderabad, Telangana. Its website is jeevanscientific.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 1 & 2 Sai Krupa Enclave Manikonda Jagir Near Lanco Hills, Hyderabad, Telangana, India – 500008
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Jeevan Scientific Technology Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Jeevan Scientific Technology operates two associated brands: Jeevan Climate and Jeevan Scientific Technology. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops modular carbon capture systems using advanced resins for CO2 removal. | jeevanclimate.com | |
| Healthcare outsourcing services are provided by Jeevan Scientific Technology. | jeevanscientific.com |
Business activity
The main business activity of Jeevan Scientific Technology is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Jeevan Scientific Technology Limited, buy the company report.
Financials of Jeevan Scientific Technology Limited
FY 2025-26 filings availableJeevan Scientific Technology Limited reported revenue of ₹61.54 Cr (up 31.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 61.54 | 46.84 | 39.65 | 36.18 | 67.79 | 46.95 | 23.94 |
| Revenue growth | +31.4% | +18.1% | +9.6% | -46.6% | +44.4% | +96.1% | - |
| EBITDA | 9.80 | 7.48 | 4.63 | 1.35 | 16.75 | 17.48 | (6.12) |
| EBITDA margin | +15.9% | +16.0% | +11.7% | +3.7% | +24.7% | +37.2% | -25.6% |
| Profit before tax | 2.09 | 0.06 | (1.61) | (3.69) | 18.02 | 13.64 | (10.55) |
| Net profit | 1.15 | 0.16 | (1.30) | (3.06) | 9.26 | 11.73 | (8.56) |
| Net profit margin | +1.9% | +0.3% | -3.3% | -8.5% | +13.7% | +25.0% | -35.8% |
| EPS (₹) | 0.61 | 0.08 | (0.84) | (1.97) | 7.81 | 7.67 | (5.61) |
| Balance sheet | |||||||
| Total assets | - | 71.21 | 62.45 | 58.83 | 63.40 | 45.69 | 41.43 |
| Net worth | - | 49.94 | 48.43 | 48.19 | 50.58 | 35.02 | 23.22 |
| Total debt | - | 20.58 | 13.41 | 10.10 | 12.55 | 10.34 | 17.95 |
| Cash & bank | - | 0.24 | 0.54 | 6.83 | 29.71 | 6.21 | 2.20 |
| Net working capital | - | 21.67 | 19.26 | 22.09 | 39.91 | 13.59 | 5.63 |
| Cash flow | |||||||
| Cash from operations | - | 10.07 | 2.89 | (6.41) | 19.56 | 4.95 | (0.01) |
| Cash from investing | - | (15.62) | (11.53) | (6.93) | (1.20) | (0.80) | (1.90) |
| Cash from financing | - | 5.24 | 2.35 | (9.54) | 5.67 | (0.13) | 0.44 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.17 | 18.28 | 21.29 | 19.07 | 12.38 | 8.80 | 10.06 | 12.51 |
| Revenue growth (YoY) | +87.2% | +107.7% | +111.6% | +52.4% | +8.6% | -31.7% | - | - |
| Other income | 0.44 | 0.17 | 0.29 | 0.14 | 0.20 | 0.33 | 0.15 | 0.23 |
| EBITDA | 5.71 | 2.95 | 4.29 | 5.23 | 2.07 | (1.78) | (0.38) | 2.08 |
| EBITDA margin | +24.6% | +16.1% | +20.2% | +27.4% | +16.7% | -20.2% | -3.8% | +16.6% |
| Depreciation | 1.80 | 1.70 | 1.61 | 1.60 | 1.69 | 1.74 | 1.77 | 1.48 |
| Interest | 0.48 | 0.44 | 0.41 | 0.54 | 0.55 | 0.54 | 0.55 | 0.43 |
| Profit before tax | 3.87 | 0.98 | 2.56 | 3.23 | 0.03 | (3.73) | (2.55) | 0.40 |
| Tax | 0.97 | 0.11 | 0.73 | 0.83 | 0.02 | (0.51) | (1.29) | 0.35 |
| Net profit | 2.90 | 0.87 | 1.83 | 2.40 | 0.01 | (3.22) | (1.26) | 0.05 |
| EPS (₹) | 1.44 | 0.43 | 1.09 | 1.52 | 0.01 | (2.03) | (0.79) | 0.03 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 53.93 | 43.61 | 38.50 | 36.18 | 56.55 | 40.47 | 20.57 |
| Revenue growth | +23.7% | +13.3% | +6.4% | -36.0% | +39.7% | +96.7% | - |
| EBITDA | 8.48 | 6.53 | 4.38 | 1.35 | 17.06 | 16.63 | (5.82) |
| EBITDA margin | +15.7% | +15.0% | +11.4% | +3.7% | +30.2% | +41.1% | -28.3% |
| Profit before tax | 2.64 | 0.77 | (1.23) | (3.62) | 18.33 | 13.17 | (9.78) |
| Net profit | 1.65 | 0.73 | (1.05) | (3.01) | 9.54 | 11.25 | (7.79) |
| Net profit margin | +3.1% | +1.7% | -2.7% | -8.3% | +16.9% | +27.8% | -37.9% |
| EPS (₹) | 0.98 | 0.46 | (0.68) | (1.94) | 8.01 | 7.36 | (5.11) |
| Balance sheet | |||||||
| Total assets | - | 64.35 | 55.02 | 57.46 | 63.40 | 46.91 | 43.14 |
| Net worth | - | 50.91 | 48.80 | 48.32 | 50.58 | 36.25 | 24.93 |
| Total debt | - | 12.88 | 5.80 | 8.84 | 12.55 | 10.34 | 17.95 |
| Cash & bank | - | 0.21 | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 |
| Net working capital | - | 23.64 | 19.34 | 21.65 | 39.91 | 14.09 | 6.93 |
| Cash flow | |||||||
| Cash from operations | - | 2.96 | 2.74 | (6.29) | 19.56 | 4.73 | (1.19) |
| Cash from investing | - | (9.84) | (4.69) | (7.27) | (1.20) | (0.80) | (1.02) |
| Cash from financing | - | 6.58 | (3.66) | (10.03) | 5.67 | (0.13) | 0.44 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.87 | 16.93 | 18.38 | 16.91 | 10.43 | 8.22 | 8.92 | 11.87 |
| Revenue growth (YoY) | +100.1% | +106.0% | +106.1% | +42.5% | +1.3% | -34.4% | - | - |
| Other income | 0.56 | 0.26 | 0.37 | 0.18 | 0.26 | 0.38 | 0.14 | 0.22 |
| Total expenses | 15.80 | 13.29 | 14.90 | 12.26 | 8.96 | 9.33 | 9.83 | 9.83 |
| EBITDA | 5.07 | 3.64 | 3.48 | 4.65 | 1.47 | (1.11) | (0.91) | 2.04 |
| EBITDA margin | +24.3% | +21.5% | +18.9% | +27.5% | +14.1% | -13.5% | -10.2% | +17.2% |
| Depreciation | 1.52 | 1.43 | 1.36 | 1.35 | 1.45 | 1.50 | 1.53 | 1.23 |
| Interest | 0.35 | 0.30 | 0.25 | 0.38 | 0.38 | 0.36 | 0.35 | 0.26 |
| Profit before tax | 3.76 | 2.17 | 2.24 | 3.10 | (0.10) | (2.59) | (2.65) | 0.77 |
| Tax | 1.01 | 0.30 | 0.64 | 0.80 | (0.01) | (0.43) | (1.31) | 0.44 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.17 | 18.28 | 21.29 | 19.07 | 12.38 | 8.80 | 10.06 | 12.51 |
| Revenue growth (YoY) | +87.2% | +107.7% | +111.6% | +52.4% | +8.6% | -31.7% | - | - |
| Other income | 0.44 | 0.17 | 0.29 | 0.14 | 0.20 | 0.33 | 0.15 | 0.23 |
| EBITDA | 5.71 | 2.95 | 4.29 | 5.23 | 2.07 | (1.78) | (0.38) | 2.08 |
| EBITDA margin | +24.6% | +16.1% | +20.2% | +27.4% | +16.7% | -20.2% | -3.8% | +16.6% |
| Depreciation | 1.80 | 1.70 | 1.61 | 1.60 | 1.69 | 1.74 | 1.77 | 1.48 |
| Interest | 0.48 | 0.44 | 0.41 | 0.54 | 0.55 | 0.54 | 0.55 | 0.43 |
| Profit before tax | 3.87 | 0.98 | 2.56 | 3.23 | 0.03 | (3.73) | (2.55) | 0.40 |
| Tax | 0.97 | 0.11 | 0.73 | 0.83 | 0.02 | (0.51) | (1.29) | 0.35 |
| Net profit | 2.90 | 0.87 | 1.83 | 2.40 | 0.01 | (3.22) | (1.26) | 0.05 |
| EPS (₹) | 1.44 | 0.43 | 1.09 | 1.52 | 0.01 | (2.03) | (0.79) | 0.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 61.54 | 46.84 | 39.65 | 36.18 | 67.79 | 46.95 | 23.94 |
| Revenue growth | +31.4% | +18.1% | +9.6% | -46.6% | +44.4% | +96.1% | - |
| Other income | 0.97 | 0.65 | 0.67 | 1.07 | 5.92 | 2.39 | 2.53 |
| Total expenses | 51.74 | 39.36 | 35.02 | 34.83 | 51.04 | 29.47 | 30.06 |
| Employee cost | 0.00 | 14.90 | 13.28 | 12.62 | 18.17 | 11.05 | 9.26 |
| EBITDA | 9.80 | 7.48 | 4.63 | 1.35 | 16.75 | 17.48 | (6.12) |
| EBITDA margin | +15.9% | +16.0% | +11.7% | +3.7% | +24.7% | +37.2% | -25.6% |
| Depreciation | 6.64 | 6.25 | 5.93 | 5.07 | 3.69 | 3.97 | 3.92 |
| Interest | 2.04 | 1.82 | 0.98 | 1.04 | 0.96 | 2.26 | 3.04 |
| Profit before tax | 2.09 | 0.06 | (1.61) | (3.69) | 18.02 | 13.64 | (10.55) |
| Tax | 1.06 | (0.01) | (0.28) | (0.61) | 6.09 | 1.91 | (1.96) |
| Net profit | 1.15 | 0.16 | (1.30) | (3.06) | 9.26 | 11.73 | (8.56) |
| Net profit margin | +1.9% | +0.3% | -3.3% | -8.5% | +13.7% | +25.0% | -35.8% |
| EPS (₹) | 0.61 | 0.08 | (0.84) | (1.97) | 7.81 | 7.67 | (5.61) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 15.83 | 15.48 | 15.48 | 15.30 | 15.30 | 15.30 |
| Reserves & surplus | - | 34.11 | 32.95 | 32.71 | 35.28 | 19.72 | 7.92 |
| Shareholders' funds (net worth) | - | 49.94 | 48.43 | 48.19 | 50.58 | 35.02 | 23.22 |
| Minority interest | - | 0.13 | 0.20 | 0.23 | 0.00 | 0.00 | 0.00 |
| Secured loans | - | 14.30 | 9.71 | 5.15 | 4.23 | 10.29 | 10.58 |
| Unsecured loans | - | 6.28 | 3.70 | 4.95 | 8.32 | 0.05 | 7.37 |
| Total debt | - | 20.58 | 13.41 | 10.10 | 12.55 | 10.34 | 17.95 |
| Total liabilities | - | 71.21 | 62.45 | 58.83 | 63.40 | 45.69 | 41.43 |
| Assets | |||||||
| Gross block | - | 74.74 | 60.21 | 52.33 | 40.85 | 45.39 | 44.75 |
| Net block | - | 34.54 | 26.67 | 24.98 | 19.07 | 27.37 | 30.54 |
| Capital work in progress | - | 4.71 | 2.81 | 1.90 | 0.00 | 0.00 | 0.00 |
| Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | - | 1.62 | 1.09 | 0.87 | 1.46 | 3.46 | 0.95 |
| Sundry debtors | - | 15.94 | 12.29 | 11.68 | 7.61 | 14.45 | 6.84 |
| Cash & bank balances | - | 0.24 | 0.54 | 6.83 | 29.71 | 6.21 | 2.20 |
| Loans & advances | - | 10.95 | 10.75 | 9.80 | 15.11 | 9.76 | 8.09 |
| Total current assets | - | 28.75 | 24.67 | 29.18 | 53.89 | 33.88 | 18.08 |
| Total current liabilities | - | 7.08 | 5.41 | 7.09 | 13.98 | 20.29 | 12.45 |
| Net working capital | - | 21.67 | 19.26 | 22.09 | 39.91 | 13.59 | 5.63 |
| Total assets | - | 71.21 | 62.45 | 58.83 | 63.40 | 45.69 | 41.43 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 0.54 | 6.83 | 29.71 | 5.68 | 2.20 | 3.67 |
| Net cash from operating activities | - | 10.07 | 2.89 | (6.41) | 19.56 | 4.95 | (0.01) |
| Net cash from investing activities | - | (15.62) | (11.53) | (6.93) | (1.20) | (0.80) | (1.90) |
| Net cash from financing activities | - | 5.24 | 2.35 | (9.54) | 5.67 | (0.13) | 0.44 |
| Net change in cash | - | (0.30) | (6.29) | (22.88) | 24.03 | 4.02 | (1.47) |
| Closing cash | - | 0.24 | 0.54 | 6.83 | 29.71 | 6.21 | 2.20 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +31.4% | +18.1% | +9.6% | -46.6% | +44.4% | +96.1% | - |
| EBITDA growth | +31.0% | +61.6% | +243.0% | -91.9% | -4.2% | +385.6% | - |
| PBT growth | +3383.3% | +9998.0% | +56.4% | - | +32.1% | +9998.0% | - |
| Net income growth | +618.8% | +112.3% | +57.5% | -133.1% | -21.1% | +237.0% | - |
| Revenue CAGR (3Y) | +19.4% | -11.6% | -5.5% | +14.8% | +37.4% | +32.0% | +9.6% |
| EBITDA CAGR (3Y) | +93.6% | -23.6% | -35.8% | - | +42.0% | +72.1% | - |
| Profitability & leverage | |||||||
| Net income margin | +1.7% | +0.2% | -3.4% | -8.5% | +17.6% | +25.0% | -35.9% |
| Return on capital employed | - | +2.8% | -1.0% | -4.3% | +27.4% | +36.5% | 0.0% |
| Return on net worth | - | +0.1% | -2.8% | -6.2% | +21.7% | +40.3% | 0.0% |
| Debt / equity | - | 0.35 | 0.24 | 0.23 | 0.27 | 0.49 | 0.66 |
| Long-term debt / equity | - | 0.26 | 0.16 | 0.10 | 0.14 | 0.27 | 0.28 |
| Interest cover | 64.56 | 147.97 | -75.38 | -27.96 | 7.35 | 16.73 | -30.28 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.69 | 0.70 | 0.78 | 1.57 | 1.04 | 0.55 |
| Inventory turnover | - | 34.57 | 40.46 | 31.06 | 27.56 | 21.29 | 40.58 |
| Debtors turnover | - | 3.32 | 3.31 | 3.75 | 6.15 | 4.41 | 2.22 |
| EPS (₹) | 0.61 | 0.08 | (0.84) | (1.97) | 7.81 | 7.67 | (5.61) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | 0.50 | 0.00 |
| Book value per share (₹) | 0.00 | 31.54 | 31.28 | 31.13 | 33.06 | 22.89 | 15.18 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.87 | 16.93 | 18.38 | 16.91 | 10.43 | 8.22 | 8.92 | 11.87 |
| Revenue growth (YoY) | +100.1% | +106.0% | +106.1% | +42.5% | +1.3% | -34.4% | - | - |
| Other income | 0.56 | 0.26 | 0.37 | 0.18 | 0.26 | 0.38 | 0.14 | 0.22 |
| Total expenses | 15.80 | 13.29 | 14.90 | 12.26 | 8.96 | 9.33 | 9.83 | 9.83 |
| EBITDA | 5.07 | 3.64 | 3.48 | 4.65 | 1.47 | (1.11) | (0.91) | 2.04 |
| EBITDA margin | +24.3% | +21.5% | +18.9% | +27.5% | +14.1% | -13.5% | -10.2% | +17.2% |
| Depreciation | 1.52 | 1.43 | 1.36 | 1.35 | 1.45 | 1.50 | 1.53 | 1.23 |
| Interest | 0.35 | 0.30 | 0.25 | 0.38 | 0.38 | 0.36 | 0.35 | 0.26 |
| Profit before tax | 3.76 | 2.17 | 2.24 | 3.10 | (0.10) | (2.59) | (2.65) | 0.77 |
| Tax | 1.01 | 0.30 | 0.64 | 0.80 | (0.01) | (0.43) | (1.31) | 0.44 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 53.93 | 43.61 | 38.50 | 36.18 | 56.55 | 40.47 | 20.57 |
| Revenue growth | +23.7% | +13.3% | +6.4% | -36.0% | +39.7% | +96.7% | - |
| Other income | 1.19 | 0.63 | 0.69 | 1.06 | 5.91 | 2.38 | 2.52 |
| Total expenses | 45.45 | 37.08 | 34.12 | 34.83 | 39.49 | 23.84 | 26.39 |
| Employee cost | 0.00 | 13.62 | 12.93 | 12.62 | 13.16 | 8.00 | 7.13 |
| EBITDA | 8.48 | 6.53 | 4.38 | 1.35 | 17.06 | 16.63 | (5.82) |
| EBITDA margin | +15.7% | +15.0% | +11.4% | +3.7% | +30.2% | +41.1% | -28.3% |
| Depreciation | 5.65 | 5.29 | 5.55 | 5.02 | 3.68 | 3.96 | 3.91 |
| Interest | 1.38 | 1.10 | 0.75 | 1.01 | 0.96 | 1.88 | 2.57 |
| Profit before tax | 2.64 | 0.77 | (1.23) | (3.62) | 18.33 | 13.17 | (9.78) |
| Tax | 0.99 | 0.03 | (0.18) | (0.61) | 6.09 | 1.92 | (1.96) |
| Net profit | 1.65 | 0.73 | (1.05) | (3.01) | 9.54 | 11.25 | (7.79) |
| Net profit margin | +3.1% | +1.7% | -2.7% | -8.3% | +16.9% | +27.8% | -37.9% |
| EPS (₹) | 0.98 | 0.46 | (0.68) | (1.94) | 8.01 | 7.36 | (5.11) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 15.83 | 15.48 | 15.48 | 15.30 | 15.30 | 15.30 |
| Reserves & surplus | - | 35.08 | 33.32 | 32.84 | 35.28 | 20.95 | 9.63 |
| Shareholders' funds (net worth) | - | 50.91 | 48.80 | 48.32 | 50.58 | 36.25 | 24.93 |
| Secured loans | - | 7.68 | 3.43 | 4.85 | 4.23 | 10.29 | 10.58 |
| Unsecured loans | - | 5.20 | 2.37 | 3.99 | 8.32 | 0.05 | 7.37 |
| Total debt | - | 12.88 | 5.80 | 8.84 | 12.55 | 10.34 | 17.95 |
| Total liabilities | - | 64.35 | 55.02 | 57.46 | 63.40 | 46.91 | 43.14 |
| Assets | |||||||
| Gross block | - | 67.52 | 53.31 | 51.33 | 40.85 | 38.51 | 37.71 |
| Net block | - | 28.72 | 20.20 | 24.03 | 19.07 | 20.53 | 23.68 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 2.00 | 2.00 | 2.00 | 0.00 | 1.03 | 1.03 |
| Inventories | - | 0.93 | 1.01 | 0.87 | 1.46 | 4.94 | 0.95 |
| Sundry debtors | - | 14.39 | 11.93 | 11.68 | 7.61 | 12.46 | 6.00 |
| Cash & bank balances | - | 0.21 | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 |
| Loans & advances | - | 14.38 | 10.78 | 9.27 | 15.11 | 7.87 | 7.85 |
| Total current assets | - | 29.91 | 24.23 | 27.94 | 53.89 | 30.95 | 16.68 |
| Total current liabilities | - | 6.27 | 4.89 | 6.29 | 13.98 | 16.86 | 9.75 |
| Net working capital | - | 23.64 | 19.34 | 21.65 | 39.91 | 14.09 | 6.93 |
| Total assets | - | 64.35 | 55.02 | 57.46 | 63.40 | 46.91 | 43.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 | 3.66 |
| Net cash from operating activities | - | 2.96 | 2.74 | (6.29) | 19.56 | 4.73 | (1.19) |
| Net cash from investing activities | - | (9.84) | (4.69) | (7.27) | (1.20) | (0.80) | (1.02) |
| Net cash from financing activities | - | 6.58 | (3.66) | (10.03) | 5.67 | (0.13) | 0.44 |
| Net change in cash | - | (0.30) | (5.61) | (23.59) | 24.03 | 3.80 | (1.77) |
| Closing cash | - | 0.21 | 0.51 | 6.12 | 29.71 | 5.68 | 1.88 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +23.7% | +13.3% | +6.4% | -36.0% | +39.7% | +96.7% | - |
| EBITDA growth | +29.9% | +49.1% | +224.4% | -92.1% | +2.6% | +385.7% | - |
| PBT growth | +242.9% | +9998.0% | +66.0% | - | +39.2% | +9998.0% | - |
| Net income growth | +126.0% | +169.5% | +65.1% | -131.6% | -15.2% | +244.4% | - |
| Revenue CAGR (3Y) | +14.2% | -8.3% | -1.7% | +20.7% | +30.5% | +28.1% | +5.6% |
| EBITDA CAGR (3Y) | +84.5% | -27.4% | -35.9% | - | +43.1% | +71.1% | - |
| Profitability & leverage | |||||||
| Net income margin | +3.1% | +1.7% | -2.7% | -8.3% | +21.6% | +27.8% | -38.0% |
| Return on capital employed | - | +3.1% | -0.9% | -4.3% | +27.7% | +33.4% | 0.0% |
| Return on net worth | - | +1.5% | -2.2% | -6.1% | +22.0% | +36.8% | 0.0% |
| Debt / equity | - | 0.19 | 0.15 | 0.22 | 0.26 | 0.46 | 0.63 |
| Long-term debt / equity | - | 0.12 | 0.07 | 0.09 | 0.14 | 0.26 | 0.27 |
| Interest cover | 48.76 | 88.71 | -64.10 | -27.52 | 7.17 | 14.84 | -26.41 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.72 | 0.74 | 0.78 | 1.43 | 1.06 | 0.55 |
| Inventory turnover | - | 44.96 | 40.96 | 31.06 | 17.67 | 13.74 | 34.86 |
| Debtors turnover | - | 3.31 | 3.26 | 3.75 | 5.64 | 4.38 | 2.01 |
| EPS (₹) | 0.98 | 0.46 | (0.68) | (1.94) | 8.01 | 7.36 | (5.11) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | 0.50 | 0.00 |
| Book value per share (₹) | 0.00 | 32.16 | 31.53 | 31.21 | 33.06 | 23.69 | 16.29 |
To see the full year-wise statements and ratios of Jeevan Scientific Technology Limited, buy the company report.
Board of directors of Jeevan Scientific Technology Limited
Jeevan Scientific Technology has 8 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jeevan Krishna Kuchipudi Also directs: Nayas Laboratories Private Limited | Director | 02 Nov 2020 | 6 Years 0 Months | Current |
| Nageswar Rao Yarllagadda Also directs: Sri Surya Wheels Private Limited | Whole-Time Director | 23 Jun 2021 | 5 Years 4 Months | Current |
| Snigdha Mothukuri Also directs: Naya Pharma Private Limited | Whole-Time Director | 02 Nov 2020 | 6 Years 0 Months | Current |
| Venkata Subba Rao Guttikonda | Director | 25 Mar 2022 | 4 Years 7 Months | Current |
| Krishna Kishore Kuchipudi Also directs: Jeevana Mitra Constructions LLP, JSTL Pharma LLP, Naya Pharma Private Limited and 3 more | Managing Director | 02 Feb 1999 | 27 Years 9 Months | Current |
| Suryaprakasa Rao Bommisetti Also directs: Samsrita Labs Limited, Bandaram Pharma Packtech Limited | Director | 25 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Jeevan Scientific Technology Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jeevan Scientific Technology Limitedthis company | ₹61.54 Cr (FY 2026) | ₹1.15 Cr | 1.9% | 31.4% | 306 | Hyderabad, Telangana, India |
| Alvogen Pharma (India) Private Limited | ₹51.32 Cr (FY 2025) | -6.0% | Bangalore, Karnataka, India | |||
| Allucent (India) Private Limited | ₹47.87 Cr (FY 2025) | 4.0% | Bangalore, Karnataka, India | |||
| Emerald Clinical Trials India Private Limited | ₹46.42 Cr (FY 2025) | -28.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Jeevan Scientific Technology Limited, buy the company report.
Auditor
Jeevan Scientific Technology Limited is audited by PALAVURI & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PALAVURI & Co. | FY 2024 | 012194S |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 30.20%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 69.80%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 30.20% | 38.00% | 38.00% | 38.00% |
| Public | 69.80% | 62.00% | 62.00% | 62.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Apr 2026 | 101289492 | Others | ₹40 Lakh | Open | |
| 29 Jan 2026 | 101244909 | Others | ₹2.55 Cr | Open | |
| 22 Jan 2025 | 101074475 | Others | ₹81 Lakh | Open | |
| 28 Aug 2024 | 100992019 | Others | ₹4.2 Cr | Open | |
| 29 Jul 2024 | 100990450 | Others | ₹95.15 Lakh | Open |
To see the full charge records of Jeevan Scientific Technology Limited, buy the company report.
Total charge records: 15 View all charges
Deals & funding
Jeevan Scientific Technology Limited has 10 deals on record (10 market trades); the latest was in October 2025.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2025 | Market trade | ₹2.61 Cr | Buyer: Rampurhat PSC Sleepers Limited , an individual Seller: an individual |
| Oct 2025 | Market trade | ₹2.51 Cr | Buyer: Rampurhat PSC Sleepers Limited , 2 individuals Seller: an individual |
| Jun 2021 | Market trade | ₹1.39 Cr | Buyer: an individual |
| Jun 2021 | Market trade | ₹1.53 Cr | Buyer: Alpha Leon Enterprises LLP Seller: Alpha Leon Enterprises LLP |
| Mar 2016 | Market trade | ₹29.2 Lakh | Buyer: Rajasthan Global Securities Private Limited Seller: an individual |
To see the full deal history of Jeevan Scientific Technology Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Jeevan Scientific Technology Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Jeevan Scientific Technology Limited has 5 MSME Form 1 returns on record between 2019 and 2020, listing 262 overdue payments to 19 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 19)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bioorganics and Applied Materials Private Limited | |||
| Bharat Science Appparatus Workshops | |||
| Smart Labtech Private Limited | |||
| an individual supplier | |||
| Mokshy Surgicals |
To see the full MSME payment records of Jeevan Scientific Technology Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Jeevan Scientific Technology has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Nayas Laboratories Private Limited | U24290TG2022PTC167401 |
To see the full group structure of Jeevan Scientific Technology Limited, buy the company report.
Employees & EPFO
Jeevan Scientific Technology Limited has a workforce of 306 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 306 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Jeevan Scientific Technology Limited, buy the company report.
GST
Jeevan Scientific Technology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACJ8112F1ZV | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jeevan Scientific Technology Limited, buy the company report.
Recent activity
Jeevan Scientific Technology Limited has 43 board changes on record since 1999: 26 appointments and 17 cessations. The latest: Bhanu Prakash Gali ceased to be Director on 29 Sep 2025.
58 earlier events are in the company report.
News
Frequently asked questions
Jeevan Scientific Technology is an active public limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 02 February 1999 (27+ years old) and is registered under CIN L72200TG1999PLC031016. Listed on BSE: 538837.
Jeevan Scientific Technology reported revenue of ₹61.54 Cr for FY 2025-26 (up 31.4% YoY) based on consolidated financials.
Jeevan Scientific Technology has 8 current directors:
- Krishna Kishore Kuchipudi - Managing Director
- Nageswar Rao Yarllagadda - Whole-Time Director
- Snigdha Mothukuri - Whole-Time Director
- Jeevan Krishna Kuchipudi - Director
- Venkata Subba Rao Guttikonda - Director
- Suryaprakasa Rao Bommisetti - Director
- Gollapinwi Mallikarjuna - Director
- Divakar Atluri - Director
The latest financial statements of Jeevan Scientific Technology on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jeevan Scientific Technology is 36AAACJ8112F1ZV, registered in Telangana.
The CIN (Corporate Identification Number) of Jeevan Scientific Technology is L72200TG1999PLC031016. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Jeevan Scientific Technology is a listed company as per MCA records. Its shares are listed on BSE (code: 538837).
Jeevan Scientific Technology was incorporated on 02 February 1999, making it 27+ years old. It is registered with the Registrar of Companies, Hyderabad.
Jeevan Scientific Technology has 10 deals on record (10 market trades); the latest was in October 2025.
The peers of Jeevan Scientific Technology by revenue are Alvogen Pharma (India) Private Limited, Allucent (India) Private Limited, Emerald Clinical Trials India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities).
Bhanu Prakash Gali ceased to be Director on 29 Sep 2025. Gollapinwi Mallikarjuna was appointed as Director on 14 Aug 2025. Thammareddy Ravi ceased to be Director on 14 Aug 2025. Jeevan Scientific Technology has 43 board changes on record in total.
Yes, Jeevan Scientific Technology is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0037959).

